3 of the Best Growth Stocks You Can Buy for Less than $100

Core Viewpoint - Finding growth stocks priced under $100 is becoming increasingly challenging, yet there are still viable options for long-term investment that are affordable [1][3]. Group 1: CRISPR Therapeutics - CRISPR Therapeutics is a promising healthcare stock currently trading at just over $51 per share, well below the $100 threshold [4]. - The company has received approval for its cell therapy, Casgevy, which targets rare blood disorders and has a price tag exceeding $2 million, indicating significant revenue potential [5]. - Although CRISPR does not generate consistent revenue and has incurred losses, it has effectively managed costs, which may lead to improved financials as Casgevy is rolled out [6][7]. Group 2: Celsius - Celsius, an energy drink company, has seen its stock price drop to below $30 after previously nearing $100, primarily due to a decline in growth rate and reduced guidance [8]. - The company has a strong partnership with PepsiCo, which invested $550 million in Celsius in 2022, providing a vote of confidence [9]. - Despite recent challenges, Celsius has potential for growth in untapped markets and has posted operating profits in three of the last four quarters [10]. Group 3: KB Home - KB Home is trading just under $83 per share and is benefiting from decreasing interest rates, which may accelerate sales in upcoming quarters [11][12]. - The company reported quarterly revenue of approximately $1.8 billion, reflecting a more than 10% increase from the previous year, and noted a strengthening in demand [12]. - With a valuation of 11 times its trailing earnings, KB Home is considered an attractive growth and value stock for investment [13].